Quality Measurement Improvement in the New Medicare Prescription Drug Benefit Michael Anderson, Pharm.D. Director Cl

1. Quality Measurement & Improvement in the New Medicare Prescription Drug BenefitMichael Anderson, Pharm.D.Director � Clinical Programs & EducationNovember 17, 2005

2. Proprietary and Confidential








10. Proprietary and Confidential






16. Proprietary and Confidential Indication Effectiveness Dosage Directions Practicality Drug�drug interaction Drug�disease interaction Duplication Duration Relative expense


Quality Measurement Improvement in the New Medicare Prescription Drug Benefit Michael Anderson, Pharm.D. Director Cl

Quality Measurement Improvement in the New Medicare Prescription Drug Benefit Michael Anderson, Pharm.D. Director Cl

Presentation Transcript

Medicare Part D Prescription Drug Benefit

Risk Adjustment in Medicare Part D Prescription Drug Benefit

Medicare D Prescription Drug Benefit

Standard Medicare Prescription Drug Benefit, 2013

New Medicare Prescription Drug Benefit: Opportunities for Quality Improvement Practical Implications

Medicare Prescription Drug Coverage

Quality Measurement and Improvement Under the New Medicare Prescription Drug Benefit

Medicare Prescription Drug Coverage

Let’s Learn Medicare! Medicare Prescription Drug Benefit

CMS 2012 Medicare Prescription Drug Benefit Symposium

Medicare Modernization Act, Part D Prescription Drug Benefit

Standard Medicare Prescription Drug Benefit, 2013

Medicare and the New Prescription Drug Benefit

Medicare Prescription Drug Coverage

Medicare Prescription Drug Coverage

QIOs: Partners for Quality Improvement Under the Medicare Drug Benefit

Prescription for Chaos The New Medicare Drug Benefit Starts Up in January

MEDICARE PRESCRIPTION DRUG BENEFIT

Medicare Prescription Drug Benefit: Part D

The Potential Impact of the New Prescription Drug Benefit on Medicare Beneficiaries

Medicare Prescription Drug Coverage

Medicare Prescription Drug Benefit Progress Report: Findings from the